Data Management Services

End-to-end data management

Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.

The company has focussed on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Avance Clinical offers globally accepted data from an established clinical trial ecosystem, that includes world-class PIs and sites that are able to rapidly access specialized patient groups.

get in touch with our
clinical operations team

Delivering more than 30 years experience of drug development expertise

Data Management Services

Avance Clinical data is accepted by all major regulatory authorities around the globe including the FDA.
The Avance Clinical Data Management Team provides accurate and precise end-to-end data management services.

World-class reputation

Our clinical data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.

In-house end-to-end clinical data management

Our highly experienced staff provides seamless in-house end-to-end clinical data management services, utilizing streamlined capture, analysis, and reporting pathways to deliver quality data sets to your team.

Our data management services

  • e-CRF development and validation using Medrio
  • CDASH conforming CRF design
  • e-PRO
  • Edit check programming
  • Medical Coding (MedDRA and WHO-DD)
  • Data cleaning and reconciliation
  • Database exports in Excel and SAS formats
  • Provision of Data Management Plan (DMP) and Edit Check Specifications

Latest News

WHY BIOTECHS CHOOSE
AVANCE CLINICAL

More than three decades of deep clinical research management experience, Avance Clinical is the largest
specialist Australian and US CRO delivering quality clinical trials in Australia, New Zealand, Asia and North America for international biotechs.

43.5%

REBATE

5-6 Wks

START-UP TIME

100%

CAPABILITIES

FDA

COMPLIANT RESEARCH